Meridian Life Science, Inc @OneMeridianLS
Leading manufacturer of #molecular #biology #reagents, #antigens, #antibodies, blockers, #dNTPs, #PCRenzymes, and mixes for #diagnosticapplications. meridianlifescience.com Wilfong Road Memphis, Tennesse Joined May 2021-
Tweets924
-
Followers171
-
Following861
-
Likes4
Still relying on cold-chain qPCR workflows? Traditional qPCR mixes depend on refrigerated storage and shipping—raising costs, complicating logistics, and slowing scale-up. As workflows expand, this dependency is becoming harder to sustain. Our NEW Liquid Ambient-Stable DNA qPCR Mixes deliver true ambient stability for 12+ months, maintaining performance in a liquid format with no need for lyophilization or air-drying. Choose the format that fits your development needs: 🔹 MDX360 – Liquid Stable Flex DNA qPCR Mix – Add primers/probes at the point of use for full customization; ideal for low–high throughput and assay optimization. 🔹 MDX364 – Liquid Stable Ready DNA qPCR Mix – A fixed, ready-to-run format with primers/probes added during manufacturing; engineered for scalable, repeatable production. Whether you’re building customizable workflows or fixed high-throughput assays, these mixes reduce cost and complexity—without compromising performance. Explore performance data/compare formats: hubs.la/Q04kB52f0 Contact a specialist/request a sample: hubs.la/Q04kDFHB0 #qPCRmastermixes #MolecularDiagnostics #AssayDevelopment #LifeSciences #PrecisionDiagnostics #NextGenDiagnostics #LiquidStableqPCR #AmbientStability #DiagnosticInnovation #ambientstableassay
Point-of-care diagnostics are transforming how and where testing happens—but challenges around enzyme stability, cost, and logistics can slow adoption. View our on-demand featured presentation "Empowering Molecular Point-of-Care Diagnostics with Ambient-Stable Chemistries" with William Ferreira, R&D Team Leader at Meridian Life Science. Explore how established and emerging molecular techniques—including qPCR, isothermal amplification, and NGS—can be adapted with ambient-stable reagent chemistries to enable faster, more scalable, and cost-effective testing at the point of care. Learn how Meridian’s technologies support: • Molecular point-of-care testing • Ambient-stable, cold-chain-free chemistries • Infectious disease diagnostics • Decentralized and near-patient testing • Rapid assay development in resource-limited settings ▶️ Watch now: hubs.la/Q04ksgrl0 Contact a specialist for more: hubs.la/Q04ks2010 #PointOfCareDiagnostics #MolecularDiagnostics #AmbientStable #ColdChainFree #DecentralizedTesting #InfectiousDisease #AssayDevelopment #LifeScienceInnovation #POCT #EnzymeStability
Meridian’s Lyo-Ready Genotyping Direct qPCR Master Mixes are engineered for ultra-sensitive SNP detection—supporting simplified direct workflows and high-confidence mutation analysis, even at very low copy numbers. Designed for commercial assay developers and molecular diagnostics manufacturers, these mixes deliver reliable performance in both liquid and lyophilized formats. Key advantages: ✅ Ultra-sensitive detection down to 1 copy using direct amplification ✅ High tolerance to common PCR inhibitors ✅ Tight fluorescence clustering for clear allele discrimination ✅ Available in liquid or lyophilized formats for extended shelf life and ambient transport Explore Meridian’s Lyo-Ready Genotyping Direct qPCR Mixes for blood, urine, stool and FFPE. View our product catalog: hubs.la/Q04kgksJ0 Contact a Specialist: hubs.la/Q04kgzNY0 #OncologyDiagnostics #LiquidBiopsy #SNPDetection #qPCR #MolecularDiagnostics #PrecisionOncology #IVD #AssayDevelopers #Lyophilization #genotyping #ambientstable
Get the Pack. Test the Difference. Seeing unexplained variability in your immunoassays? Interference could be the culprit. Try Meridian’s Antibody Interference Blocker Sample Pack and evaluate the impact on assay performance and data reliability—before committing. ☑️ Proven blockers for common immunoassay interferents ☑️ Targets HAMA, RF, and heterophilic antibodies ☑️ Works across ELISA, CLIA, and LFA platforms Choose from serum-based or animal-free options to match your workflow. Explore our blocker portfolio: hubs.la/Q04k7Dtf0 Get your sample pack today: hubs.la/Q04k7FdM0 #immunodiagnostics #antibodyblockers #assaydevelopment #HAMA #rheumatoidfactor #antibodyinterference #CLIA #ELISA #interferenceblockers #immunoassayblockers #HAMA #MouseIgG
Democratizing Access to NGS for Precision Oncology As next-generation sequencing expands beyond centralized labs, access, stability and simplicity are becoming essential to advancing precision oncology worldwide. Meridian is helping to lead this shift with ambient-stable, lyophilized library-preparation reagents designed to remove traditional barriers and enable broader adoption of NGS. What's the Impact? 🔹 Eliminates cold-chain dependence 🔹 Simplifies and streamlines workflows 🔹 Delivers consistent performance 🔹 Supports automation while reducing cost and environmental impact 🔹 Enables fast, reliable, cost-effective sequencing in resource-limited settings By stabilizing key steps across the library prep workflow, we are helping democratize NGS—empowering more labs to bring precision oncology to patients everywhere. Explore the data and download the poster to learn more. hubs.la/Q04jX-PD0 Visit our website: hubs.la/Q04jYglY0 #NGS #PrecisionOncology #Genomics #LifeSciences #MolecularDiagnostics #Biotech #nextgensequencing #LibraryPrep #eliminatecoldchain #pointofcare #ambientstablereagents
Sepsis remains a critical global health challenge where every hour counts. Traditional blood culture methods can be hampered by long turnaround times and inconsistent positivity rates — creating an urgent need for faster, more sensitive molecular approaches. Our clinical case study with PILOT GENE evaluates droplet digital PCR (ddPCR) for bloodstream infection detection, featuring Meridian’s Lyo-Ready qPCR Mix (MDX024) to support robust and reproducible assay performance. Key findings include: • Accelerated diagnostics with significantly reduced time to actionable results • Enhanced pathogen detection in clinical samples • Added insights into antimicrobial resistance • Consistent, reliable performance across formats and sample types when using Lyo-Ready qPCR MIx These results highlight the transformative potential of ddPCR-based workflows in sepsis diagnostics — and Meridian’s commitment to enabling clinical innovation with reliable molecular reagents. Download the full case study to explore the methodology, clinical insights, and implications for advancing sepsis diagnostics. hubs.la/Q04jKhFg0 #SepsisDiagnostics #ddPCR #MolecularDiagnostics #ClinicalInnovation #qPCR #InfectiousDisease #LyophilizedPCR #SepsisDetection #AssayDevelopers
Heading to ESHG 2026 in Gothenburg!? Stop by Booth #462 to discover how ambient-stable molecular solutions can help simplify assay development and support commercialization. From liquid ambient-stable qPCR master mixes to fully lyophilized NGS workflows, Meridian’s technologies are designed to help: ✔ Simplify laboratory workflows ✔ Reduce cold-chain storage and shipping requirements ✔ Support assay stability and reliability ✔ Accelerate the path from development to commercialization Featured at ESHG: 🧬 Liquid ambient-stable DNA qPCR master mixes 🧬 NEW lyophilized NGS enzymatic DNA fragmentation kit 🧬 Fully lyophilized NGS library preparation solutions Whether you’re developing molecular diagnostics, genetic testing assays, or next-generation sequencing workflows, our team is ready to discuss solutions tailored to your development goals. Visit Booth #462 | June 13–16 | Gothenburg, Sweden Schedule a meeting: hubs.la/Q04jyZzq0 Visit our event page: hubs.la/Q04jz2Qt0 #ESHG2026 #HumanGenetics #Genomics #MolecularDiagnostics #NGS #qPCR #AssayDevelopment #GeneticResearch #Diagnostics #LifeScience #nextgensequencing #libraryprep @eshgsociety
As warmer weather returns and mosquito activity increases across many regions, the need for accurate tropical and vector-borne disease testing remains a critical priority. Meridian Life Science helps diagnostic manufacturers develop reliable immunoassays for malaria, dengue, and Zika with high-quality antigens, antibodies, and blockers designed to support assay performance from development through deployment. Our portfolio includes: • Malaria targets including HRP-2, pLDH, aldolase, MSP1, and CSP • Dengue reagents for NS1, IgM, and IgG assay development • Zika solutions, including ZEROX-REACT™ ZIKA Envelope Antigen, engineered to minimize cross-reactivity with other flaviviruses Whether developing laboratory-based or point-of-care assays, our reagents help support sensitive, specific, and reliable test development for global health applications. Learn more: hubs.la/Q04jmMKx0 Contact a specialist: hubs.la/Q04jmM930 #GlobalHealth #AssayDevelopment #ImmunoDiagnostics #DiagnosticDevelopment #TropicalDiseases #VectorBorneDiseases #Malaria #Dengue #Zika #LifeScience #pointofcare #immunoassays
Cold-chain requirements can create real challenges for diagnostic assay developers — from frozen shipments and limited storage space to increased waste and workflow disruption. Meridian’s Liquid Ambient-Stable DNA qPCR Mixes are designed to help reduce that pressure with 12-month ambient stability in a liquid format, without converting assays to a dry state. Choose the format that fits your workflow: MDX360 Liquid Stable Flex DNA qPCR Mix: For teams that need flexibility to add primers and probes at the point of use. MDX364 Liquid Stable Ready DNA qPCR Mix: For developers and manufacturers looking for a more ready-to-run liquid qPCR format. One technology. Two purpose-built formats. More flexibility for development, manufacturing, and point-of-care applications. Explore the data and compare formats: hubs.la/Q04j2FmN0 Contact a Specialist: hubs.la/Q04j2Xcb0 #qPCR #AmbientStable #ReduceColdChain #MolecularDiagnostics #DiagnosticsDevelopment #AssayDevelopment #LifeScience #MolecularReagents #PointOfCareTesting
Is your workflow struggling with clean amplification, balanced coverage, and downstream sequencing accuracy? In a recent customer evaluation, our MDX122 qPCR mix was put to the test in a 177-plex amplicon tNGS assay—and delivered performance equivalent to their commercial kit. Find out how our MDX122 performed across: • Amplification balance • GC-rich targets • Primer-dimer tendency • Uniformity • Downstream accuracy Get the data in our new application note "Inside an Assay Developer’s Study – qPCR for tNGS" hubs.la/Q04j36TT0 Curious how the right qPCR chemistry can strengthen your results?hubs.la/Q04j362p0 #qPCR #targetedNGS #MolecularDiagnostics #AssayDevelopers #PCROptimization #NGSChemistry #ApplicationNote #Genomics #MultiplexPCR #nextgensequencing #tNGS
Are you still battling inconsistent results in your immunoassays? Interference from HAMA, RF, and other heterophilic antibodies can skew data accuracy—especially in post-COVID samples. In this white paper, Meridian introduces TRU Block™, a next-generation universal blocker that delivers stronger, broader protection than traditional agents like Mouse IgG: ✅ Broad coverage against HA, HAMA, and RF ✅ High-affinity binding even at lower concentrations ✅ Proven performance across ELISA, CLIA, and lateral flow assays Enhance assay reliability and reduce costs on retesting Download the white paper: hubs.la/Q04hS-v60 Explore our portfolio of blockers: hubs.la/Q04hSH5T0 Speak to a specialist to request a sample: hubs.la/Q04hT8Dg0 #Immunoassays #AssayDevelopment #TRUBlock #ImmunoDiagnostics #ELISA #LifeScienceDiagnostics #ClinicalLaboratory #HAMA #IVD #LateralFlow #CLIA
For today’s diagnostic assays, animal-free blockers raise the bar even further. They deliver consistently low background, superior lot-to-lot reproducibility, and a defined, ethical alternative to serum-derived materials. That consistency makes them especially well-suited for automated, high-throughput, and globally scaled platforms. Assay interference can quietly undermine immunoassay performance—leading to false positives, unstable signals, and reduced confidence in results. High-quality immunoassay blockers are essential for maintaining assay integrity. They help minimize non-specific binding and reduce interference from HAMA, rheumatoid factor (RF), and heterophilic antibodies—protecting both sensitivity and specificity. Explore our portfolio of high-performance immunoassay blockers: ➡️ Animal-Free HAMA Blockers – Low background, defined composition ➡️ K-BLOCK™ / Mouse-FREE IgG – High-performance, animal-free universal blockers ➡️ TRU Block™ ULTRA, TRU Block™, TRU Block™ 3 – Proven protection against common assay interference ➡️ Mouse IgG – HAMA Blocker – Targeted protection for mouse monoclonal-based assays Consistent blockers. Cleaner data. Greater confidence. Learn more: hubs.la/Q04hFbRp0 Request a sample: hubs.la/Q04hDYKD0 #ImmunoassayBlockers #AssayOptimization #ImmunoDiagnostics #IVDDevelopment #AssayInterference #LifeSciences #Biotech #IgGBlocker #MouseFreeBlocker #MouseFreeReagents
Liquid biopsy is transitioning from a research-driven concept to clinically actionable tools and that shift is starting to have real impact. Advances in next-generation sequencing, molecular detection sensitivity and data analytics are now enabling the identification of genomic alterations that were previously undetectable. This has resulted in earlier insights, more precise stratification and improved monitoring opportunities in oncology workflows. Liquid biopsy is transitioning from a research-driven concept to clinically actionable tools and that shift is starting to have a real impact. academia, diagnostics, pharma and regulatory bodies came together to address critical challenges like validation, reproducibility and standardization. Here’s what’s shaping the future of liquid biopsy: 🔹 The shift from discovery to clinical implementation 🔹 Expansion beyond blood into other biofluids 🔹 The growing role of AI and advanced data analysis 🔹 Increased collaboration across the industry 🔹 Heightened demand for highly sensitive and reproducible assays As the field advances, ensuring consistent, reliable performance will be essential to unlocking the full potential of liquid biopsy in precision oncology. Read the full blog to get more insight: hubs.la/Q04hw6P-0 #LiquidBiopsy #CancerDiagnostics #PrecisionOncology #MolecularDiagnostics #Genomics #NextGenSequencing #BiotechInnovation #AIDiagnostics #LifeSciences #cancerbiomarkers #pointofcare
Meridian is heading to ESHG 2026 in Gothenburg! We’re excited to exhibit at the European Society of Human Genetics (June 13-16) and invite you to visit us at Booth #462 to explore solutions designed to simplify and accelerate molecular assay development and commercialization. At the conference, we’ll be showcasing: 🧬 Liquid ambient-stable DNA qPCR master mixes 🧬 Our newly launched lyophilized NGS enzymatic DNA fragmentation kit 🧬 Fully lyophilized NGS library preparation solutions Our ambient-stable technologies are engineered to help improve assay stability and reliability, maintain high sensitivity, simplify workflows and reduce cold-chain dependency. By supporting faster development timelines and a smoother transition from R&D to commercialization, these innovations help enable broader access to next-generation diagnostics. Schedule a meeting with our team or stop by Booth #462 to learn how Meridian can help streamline workflows, reduce operational complexity and support faster innovation in molecular diagnostics and genetic research. We look forward to seeing you in Gothenburg! Schedule a meeting: hubs.la/Q04h81VJ0 Visit our Event Page: hubs.la/Q04h7Y390 #ESHG2026 #HumanGenetics #Genomics #MolecularDiagnostics #NGS #qPCR #AssayDevelopment #GeneticResearch #Diagnostics #LifeScience #nextgensequencing #libraryprep @eshgsociety
What if qPCR reagents no longer needed to depend on the cold chain? Cold-chain requirements can add cost, complexity, and risk to molecular assay development and distribution. Meridian’s Liquid Ambient-Stable qPCR Mixes help address these challenges with ready-to-use liquid reagents engineered for ambient temperature stability. These liquid-format qPCR mixes are designed to simplify workflows, reduce logistics challenges, and support more scalable molecular testing without compromising performance. Key advantages include: ✅ 12+ months of ambient temperature stability ✅ Reduced reliance on cold-chain shipping and storage ✅ Easier handling with ready-to-use liquid formats ✅ Flexible options for decentralized testing and high-throughput labs ✅ Greater support for sustainable and reliable assay development As molecular diagnostics continue to expand globally, removing cold-chain barriers can help improve accessibility, efficiency, and resilience across the testing landscape. Watch the video to see how Meridian’s Liquid Ambient-Stable qPCR Mixes are helping transform assay development: hubs.ly/Q04h7Sdw0 Learn more | Contact a Specialist hubs.ly/Q04h8hs90 #qPCR #Diagnostics #MolecularDiagnostics #LifeSciences #ColdChainFree #AssayDevelopment #AmbientStableReagents #qPCR #LiquidqPCRmixes
The future of STI testing is being shaped by speed, access, and innovation. As STI rates continue to challenge public health systems worldwide, diagnostic developers are looking for solutions that can support earlier detection, broader access, and more flexible testing models. Meridian’s GEN-sponsored eBook takes a closer look at how molecular diagnostics and immunoassays are helping move STI testing beyond traditional lab settings and into clinics, community programs, point-of-care environments, and at-home collection models. Inside the eBook, explore: 🔹 How STI testing technologies have evolved over time 🔹 Why point-of-care, self-collection, and at-home testing are gaining momentum 🔹 Emerging trends such as multiplexing, ambient-stable reagents, and digital connectivity 🔹 Lessons from four decades of progress in HIV diagnostics As testing becomes more accessible and adaptable, these innovations are helping reduce barriers, support earlier intervention, and improve public health outcomes. Download the free eBook: hubs.la/Q04g-5ZS0 Learn more about our STI Assays: hubs.la/Q04g-Ndx0 #STIDiagnostics #STDtesting #STDprevention #MolecularDiagnostics #Immunoassays #STI #PublicHealth #LifeSciences #PointOfCare #HealthcareInnovation @GENbio
As our Women’s Health Week series comes to a close, we’re highlighting the importance of cervical cancer screening and the role oncoviruses can play in cancer development. Viruses such as HPV, HBV, HCV, EBV and HTLV-1 are associated with cancer progression, and co-infections may further intensify their effects. In cervical cancer, HPV detection remains especially important as screening strategies continue to evolve. According to the American Cancer Society, cervical cancer is most frequently diagnosed in women ages 35 to 64, and cases are rarely seen in women who have received regular screening before age 65. As traditional Pap smears are increasingly complemented or replaced by HPV DNA tests, PCR-based assays offer sensitive detection of multiple HPV types and may support expanded access through patient self-collection-compatible formats. Meridian supports viral oncology research and multiplex assay development with high-performance antigens, antibodies and molecular reagents for sensitive, scalable detection. Meridian’s Lyo-Ready Genotyping Direct qPCR Urine Mix is designed to support fast, precise and reproducible allelic discrimination from urine samples, helping assay developers advance urine-based genotyping workflows. Learn more about viral co-infections and cancer progression: hubs.la/Q04gNMTw0 Explore Meridian’s Lyo-Ready Genotyping Direct qPCR Urine Mix: hubs.la/Q04gNJcN0 #WomensHealthWeek #WomensHealth #EndHPV #CancerPrevention #ViralOncology #LiquidBiopsy #STIdiagostics #DetectOncoviruses #CervicalCancerDetection #NWHW
Women’s Health Week highlights the importance of advancing care for women at every stage of life and how immunoassays continue to play a critical role in women’s health and fertility diagnostics. As testing moves toward more personalized and decentralized care, sensitivity, specificity and reproducibility remain essential for generating clinically meaningful results. From fertility clinics to outpatient and emerging point-of-care settings, assay developers need solutions that support automation, higher throughput and global consistency. Meridian Life Science offers a comprehensive portfolio of immunoassay reagents to support women’s health and fertility testing, including: • high-affinity antibodies and matched pairs for reliable detection of hCG, LH, FSH, estradiol, progesterone, prolactin and TSH • native and recombinant antigens optimized to support assay development • interference mitigation solutions designed to reduce non-specific binding and antibody-mediated interference. Together, these solutions help developers build robust assays across diverse sample types and platforms. Explore our full range of hormone markers and immunoassay solutions. hubs.la/Q04gDtzv0 Contact a Specialist: hubs.la/Q04gBVdl0 #NWHW #WomensHealthWeek #FertilityTesting #Immunoassays #AssayDevelopment #HormoneTesting #Diagnostics #LifeScience #PrecisionDiagnostics #HormoneMarkers #AntibodyInterference
Colorectal cancer remains a major health concern for women and is the second leading cause of cancer death overall in the United States. For adults at average risk, regular screening is recommended beginning at age 45, and detecting colorectal cancer early offers the best chance for successful treatment. While colonoscopy and sigmoidoscopy have long been established screening methods, stool-based tests continue to gain momentum because they are non-invasive and can be completed at home. In particular, multitarget stool DNA testing (FIT-DNA or mt-sDNA) has seen growing adoption since its FDA approval in 2014, helping expand access to convenient screening options by identifying biomarkers associated with colorectal neoplasia. Evidence has shown strong performance of stool DNA testing in screening populations, including adults in the 45 to 49 age group, as screening guidelines continue to emphasize earlier detection. Meridian’s Liquid Biopsy Stool qPCR mixes are designed to support the development of multitarget stool DNA assays, helping assay developers build robust, high-performance workflows for stool-based molecular testing. By enabling innovative non-invasive approaches, these solutions can contribute to better screening strategies and improved outcomes for women and all patients. Learn more: hubs.la/Q04gpvTH0 Request a sample: hubs.la/Q04gpmS-0 #coloncancer #cancerscreening #liquidbiopsy #womenshealthweek #NWHW #precisiononcology #pointofcare #womenspreventativehealth
During Women’s Health Week, it’s important to recognize that breast cancer remains a leading cause of cancer-related death, with approximately 2.3 million new cases diagnosed worldwide each year. The traditional approach to diagnosing breast cancer relies on immunohistochemistry (IHC), a method that is time-consuming and requires skilled pathologists. However, this publication in Biochemistry and Biophysics Reports (hubs.la/Q04gcGJv0) demonstrates the potential to replace IHC with multiplex qPCR analysis using the four standard biomarkers currently used in IHC: estrogen receptor, progesterone receptor, HER2 and Ki-67 proteins. With the millions of breast cancer screening tests performed each year, high-throughput qPCR technology has the potential to improve breast cancer screening and dramatically decrease the turnaround time and cost, while improving the accuracy of cancer detection. Meridian has created high-concentration and glycerol-free enzymes and master mixes to help high-throughput assay developers reduce manufacturing time and produce user-friendly assays. They are designed to minimize sample variation, reduce background noise, facilitate quicker reactions and maintain high-sensitivity levels. Ready to optimize your molecular assays for breast cancer screening? Learn more: hubs.la/Q04gcMC50 Request a sample: hubs.la/Q04gcLd_0 #BreastCancerAwareness #MolecularDiagnostics #CancerScreening #qPCR #ClinicalDiagnostics #LabInnovation #LifeScience #breastcancerdiagnostics #breastcancerscreening #PointofCare #Oncology #NWHW #WomensHealthWeek
OptiGene Limited @OptiGeneLtd
631 Followers 1K Following OptiGene is a trusted molecular diagnostics company dedicated to the real-time detection & identification of bacteria and viruses.
Apples @Apple21_777
0 Followers 34 Following
BioTalk Unzipped @BiotalkUnzipped
4 Followers 79 Following Unzipping the Stories Behind Medical Progress by sharing the latest and greatest advances in biopharmaceuticals and medical technologies in a fun, entertaining,
Sarafianos Lab @SarafianosLab
1K Followers 1K Following Molecular virology, structural biology, HIV, SARS-CoV-2, HBV, Mpox, Nipah virus, drug resistance, antivirals...
Aurora Pro Scientific... @AuroaPro
1K Followers 4K Following AuroraPro is an U.S-based company committed to provide the scientific community with the most innovative tools for microfluidics and liquid handling instruments
Vera @Gc59lywJDV5K4m
162 Followers 6K Following
Grady Plocek @GPlocek97923
10 Followers 154 Following
Uitaoxui @Uitaoxui611
52 Followers 212 Following
BOC Sciences @BOCSciences
536 Followers 2K Following Chemicals and Biochemicals Preclinical CRO Services CDMO Services
Shanghai MG Biotechno... @shmgbio2017
1 Followers 253 Following
Chrysalis @ChrysalisGxP
51 Followers 383 Following Set the pace, lead the way and take full control of your product's manufacturing journey with customizable cleanroom hosting and GxP services.
Ruiger @Ruiger72671
6 Followers 513 Following
Otirorsui @Otirorsui84998
5 Followers 528 Following
Denise Marquez @VolYulia_
174 Followers 312 Following Business minded with a wanderer’s soul. Exploring the world one destination and opportunity at a time. Staying grounded in simplicity.
Prognoza Dataminds @PrognozaD0509
29 Followers 974 Following Specializes in KOL Identification, KOL Profiling, KOL Mapping, Pubs and Clinical Trials Analysis
Nano 2026 @AngelicaCa15482
36 Followers 1K Following Shaping the Future through Advanced Nanomaterials and Smart Innovations
rm_718 @718_rm
0 Followers 42 Following
MediciNova, Inc. @MediciNovaInc
230 Followers 655 Following A publicly traded (Nasdaq: MNOV) biopharmaceutical company that is developing novel therapeutics for disorders with unmet medical needs.
Gordon Corwin @GordonCorw60832
157 Followers 5K Following
Samson Extracts @SamsonExtracts
24 Followers 272 Following Your go to source for CBD isolate- Samson Extracts is a vertically integrated GMP Extraction facility- Email [email protected] for more details
COSMAS4BAO @CosmasOba
1K Followers 2K Following A biochemist ,politically active,NAAGSU program coordinator,SA on political matter for Nalss,frm progessive Ekiti of Bao,Proudly A Boy From Ijan Ekiti
Eericar @Eericar07173
33 Followers 1K Following
Eleece @Eleece729
37 Followers 2K Following
Shamiya Parwern @ShamiyaParween
1 Followers 8 Following
Emwibe @Emwibe9680905
74 Followers 3K Following
Efrudou @efrudou65279
8 Followers 161 Following
Sajawo @sajawobio
16 Followers 100 Following Biotech consultancy with a people focus. Smart talent strategies & seamless HR operations powering growth in life sciences.
Elise Biopharma @elisebiopharma
105 Followers 2K Following CDMO | Biologics | Microbial | Mammalian | cGMP
DividendAristo🇺�... @Plerwor7876
36 Followers 2K Following 15-30% Monthly | 2 High-Conviction Stocks.Short-Term Gains: 15-20% in Days/Weeks.DM "JOIN" for WhatsApp Alerts. Live Trade Signals • Market Analysis
Irnifgu @Irnifgu53568
41 Followers 2K Following
Epoowe @Epoowe358068
29 Followers 2K Following
Microbix @Microbix
435 Followers 609 Following
DanaThomson @8qu7tSDpjr9Wm
2 Followers 74 Following
ScientificLabShow @SciLabShow
940 Followers 986 Following #SciLabShow2026 is making a return on 13th May 2026. More details coming soon ...
Society for Mucosal I... @socmucimm
5K Followers 447 Following The Society for Mucosal Immunology (SMI) promotes excellence in research and education in mucosal immunology and fosters communication among immunologists
REGENXBIO @REGENXBIO
2K Followers 178 Following REGENXBIO is dedicated to transforming the lives of people suffering from severe diseases with significant unmet medical need through our NAV® gene therapy.
European Biotech @EuroBiotechNews
4K Followers 1K Following First and foremost in European biotech. European Biotechnology is your source for substantial information on the Life Science markets of Europe.
Journal of Neuro-Onco... @JNeurooncol
9K Followers 222 Following The official twitter account for the Journal of Neuro-Oncology (JNO), the official journal of the AANS/CNS Section on Tumors
Microbiome @MicrobiomeJ
21K Followers 2K Following A family of journals from @BioMedCentral that seek to unite investigators conducting microbiome research in environmental, agricultural, and biomedical arenas.
Mucosal Immunology @MucosalImmunol
8K Followers 301 Following Official journal for the Society for Mucosal Immunology @socmucimm EIC @BenJMarsland https://t.co/2QZUURlMMd
Nature Immunology @NatImmunol
71K Followers 170 Following Nature Immunology is a multidisciplinary journal that publishes papers of the highest quality and significance in all areas of immunology.
HIVinfo.NIH.gov @HIVinfo_NIH
15K Followers 391 Following Official account of https://t.co/3KFPRBcmhX. Offering information on HIV/AIDS treatment, prevention, and research. (Privacy Notice: https://t.co/CEuIC7ckwQ…)
AHRQ @AHRQGov
74K Followers 67 Following U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality
MicrobeTV @profvrr
201K Followers 357 Following 🌍 Earth's Virology Professor 🎙 https://t.co/Z9gk3N2HaS host 🎥 https://t.co/GhFkgkbJBI
FOCIS @FOCISimmunology
2K Followers 412 Following The Federation of Clinical Immunology Societies exists to improve human health through immunology, providing novel education & cross-discipline networking opps.
Annovis Bio @AnnovisBio
822 Followers 196 Following Developing RNA-targeted therapies for Alzheimer's disease (AD) and Parkinson's disease (PD). Lead candidate buntanetap in Phase 3 trials. NYSE: ANVS
Oncogene Journal @oncogenejournal
3K Followers 2K Following Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research.
HHS @HHSGov
1.7M Followers 40 Following Official account of the U.S. Department of Health & Human Services | Follow @SecKennedy | For latest news follow @HHSResponse | MAHA 🇺🇸
iLab Solutions Ltd @iLabSolutionsGB
74 Followers 235 Following The UK's leading company specialising in FPLC separation systems. Contact Us: E: [email protected] T: +44 (0) 333 404 3388
Clinical & Experiment... @CEIjournal
3K Followers 546 Following The journal of #translational #immunology 🔃 @britsocimm journal publishing high-quality & impactful research since 1966 Editor-in-Chief: Prof @Mauri_group
Immunity @ImmunityCP
72K Followers 320 Following Cutting-edge research in immunology from around the world. This account is no longer monitored, and content is automated. Join us on LinkedIn!
Nature Rev Immunol @NatRevImmunol
70K Followers 954 Following We publish immunology reviews. Find us here too: https://t.co/IrscA6xKVA
Human Immunology News @humanimmunenews
15K Followers 791 Following The online resource for researchers studying the human immune system. Part of the @STEMCELLTech Science News service.
Molecular Therapy Fam... @MolTherapy
4K Followers 336 Following The leading family of journals in cell and gene therapy. Journals include Molecular Therapy, Advances, Nucleic Acids, and Oncology.
Gene Therapy Net @genetherapynet
3K Followers 883 Following Gene Therapy Net is the web resource for patients and professionals interested in gene therapy.
PASCV @thepascv
995 Followers 422 Following PASCV gives you the invaluable opportunity to network with hundreds of other professionals whose life’s work is the same as yours. Become a member today.
Seegene @Seegene_HQ
2K Followers 88 Following The global leader in multiplex molecular diagnostics Seegene tirelessly pursues innovation and takes on new challenges to build a better future for humanity
Cyclo Therapeutics, I... @Cyclodexpert
663 Followers 141 Following Dedicated to developing life-changing medicines for patients and families living with challenging diseases
Cancer Gene Therapy @cgtnature
679 Followers 111 Following The essential gene & cellular therapy resource for cancer researchers & clinicians.
Oxford BioDynamics @OxBioDynamics
481 Followers 203 Following OBD is a global biotech company advancing personalized healthcare by developing and commercializing #PrecisionMedicine tests for life-changing diseases.
Microbix @Microbix
435 Followers 609 Following
MAIA Biotechnology, I... @MAIABiotech
611 Followers 254 Following MAIA Biotech is a targeted therapy, immuno-oncology company focused on the development and commercialization of first-in-class drugs. $MAIA
Virax Biolabs @Virax_Biolabs
173 Followers 26 Following An innovative biotechnology company focused on detection of immune responses to & diagnosis of viral diseases. NASDAQ : VRAX (We may post 3rd party links.)
Spear Bio @SpearBio
22 Followers 27 Following Advancing life-science research and clinical development by enabling laboratories to perform ultrasensitive immunoassays on microsamples at scale.
Applied BioMed Resear... @abiomedrc
12 Followers 10 Following
Labcorp @Labcorp
9K Followers 223 Following Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly #InPursuitOfAnswers.
Seegene USA @SeegeneUSA
2K Followers 1K Following Seegene is a leading developer of multiplex molecular assays. Its high multiplex Real-time PCR assays can simultaneously detect multiple targets for infections.
Newsweek @Newsweek
3.4M Followers 588 Following Newsweek provides in-depth analysis, news and opinion about international issues, technology, business, culture and politics.
NACCHO @NACCHOalerts
27K Followers 3K Following National Association of County and City Health Officials (NACCHO) is the national organization representing local #publichealth departments. RTs ≠ endorsements.
CDC Diabetes @CDCDiabetes
14K Followers 202 Following This account is no longer active, and our content has moved to https://t.co/JgBEpYrrQf. Follow us there for more.
FDA Drug Information @FDA_Drug_Info
345K Followers 61 Following Receive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or [email protected]. Privacy Policy - https://t.co/K2nAJlm94m.
Lab Innovations @LABINNOVATIONS
3K Followers 2K Following The UK's largest lab event for all sectors, inspiring the future of laboratories for over a decade 🧪 🗓 4 & 5 November 2026 https://t.co/y9zvpW3sYK
CDC Director @CDCDirector
337K Followers 472 Following @CDCgov Note: Posts prior to 1/20/25 were from former CDC directors. Privacy policy: https://t.co/qNVn53Yrr7 #publichealth #science #government
Camlab @Camblab
1K Followers 536 Following Camlab - part of the Calibre Scientific Group. Providing solutions for all of your laboratory needs.
UCSC Genome Browser @GenomeBrowser
19K Followers 76 Following The UCSC Genome Browser is a public, freely available, open-source web-based graphical viewer for the display of genome sequences and their annotations.
Medscape @Medscape
269K Followers 34K Following Medscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.
Johns Hopkins Center ... @BSPH_CHS
689K Followers 1K Following The Johns Hopkins Center for Health Security works to protect people’s health from the consequences of epidemics and disasters. RTs not endorsement.
Nathan Pearson @GenomeNathan
7K Followers 1K Following Human, genomicist. Ok, human genomicist...bringing DNA to life, for good, for science, for free, at https://t.co/f49Ew06307.
World Health Organiza... @WHO
12.6M Followers 2K Following We are the UN’s health agency - #HealthForAll. Always check our latest tweets for updated advice/information. We will respond to mis-and-disinformation.
Total Laboratory Serv... @TotalLabService
2K Followers 2K Following Total Laboratory Services, UK based company specialising in the Validation, Maintenance and Repair of Dissolution and related instruments. UK agent for Erweka.
PharmaShots | Ilumina... @Pharmashot
2K Followers 4K Following PharmaShots | Your partner in biopharma & healthcare insights. Connecting decision-makers & brands through sharp news, impactful insights and leader interviews
















